How ESR1 Inhibitors Transform Breast Cancer Care
ESR1 inhibitors are revolutionizing advanced breast cancer treatment, targeting resistance in hormone receptor-positive cases with groundbreaking precision. From Elacestrant’s impactful role to emerging therapies like Imlunestrant, the expanding arsenal promises significant advances. Personalized treatment strategies and ongoing research enhance outcomes, marking a pivotal shift towards more effective and tailored oncology solutions. Understanding Esr1 Inhibitors In […]
3 minute read